Difference between revisions of "De Nigris V"
From Bioblast
Beno Marija (talk | contribs) |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 10: | Line 10: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
==Participated at== | ==Participated at== | ||
* [[IOC70]] | ::::* [[IOC70| IOC70 Barcelona ES]] | ||
Latest revision as of 18:14, 12 February 2018
| Name | De Nigris Valeria, |
|---|---|
| Institution | August Pi i Sunyer Biomedical Research Institute
IDIBAPS Barcelona |
| Address | , |
| City | Barcelona |
| State/Province | |
| Country | Spain |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Ejaz 2016 Diabetes | 2016 | Ejaz A, Martinez-Guino L, Goldfine AB, Ribas-Aulinas F, De Nigris V, Ribó S, Gonzalez-Franquesa A, Garcia-Roves PM, Li E, Dreyfuss JM, Gall W, Kim JK, Bottiglieri T, Villarroya F, Gerszten RE, Patti ME, Lerin C (2016) Dietary betaine supplementation increases Fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice. Diabetes 65:902-12. |
